Meprobamate: licence to be cancelled

Source:
GOV UK
Publisher:
Medicines and Healthcare products Regulatory Agency
Publication date:
18 April 2016

Abstract

Following an EU wide review of meprobamate, the remaining licence holder in the UK has ceased manufacturing and the licence will be cancelled by the end of 2016.